Paroxetine Controlled Release: A Viewpoint by Ben Green

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.6, 2004-01, pp. : 365-366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paroxetine Controlled Release

By Bang L.M. Keating G.M.

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 355-364

Adis International

Access to resources Recommend Favorite

Paroxetine controlled-release: benefits in fibromyalgia

Inpharma, Vol. 1, Iss. 1438, 2004-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

In Canada, a Public Advisory warning against the concomitant use of Paxil [paroxetine] or Paxil controlled-release (CR) and Orap [pimozide]

Reactions Weekly, Vol. 1, Iss. 1063, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Health Canada has approved GlaxoSmithKline's controlled-release formulation of paroxetine

Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Caspofungin: A Viewpoint by Ben E. De Pauw

By De Pauw B.E.

Drugs, Vol. 61, Iss. 8, 2001-01 ,pp. : 1130-1131

Adis International

Access to resources Recommend Favorite